Literature DB >> 17576771

TRB2, a mouse Tribbles ortholog, suppresses adipocyte differentiation by inhibiting AKT and C/EBPbeta.

Takahiro Naiki1, Eiko Saijou, Yuichiro Miyaoka, Keisuke Sekine, Atsushi Miyajima.   

Abstract

Adipocyte differentiation is regulated by a complex array of extracellular signals, intracellular mediators and transcription factors. Here we describe suppression of adipocyte differentiation by TRBs, mammalian orthologs of Drosophila Tribbles. Whereas all the three TRBs were expressed in 3T3-L1 preadipocytes, TRB2 and TRB3, but not TRB1, were immediately down-regulated by differentiation stimuli. Forced expression of TRB2 and TRB3 inhibited adipocyte differentiation at an early stage. Akt activation is a key event in adipogenesis and was severely inhibited by TRB3 in 3T3-L1 cells. However, the inhibition by TRB2 was mild compared with severe inhibition by TRB3, though TRB2 suppressed adipogenesis as strongly as TRB3. Interestingly, TRB2 but not TRB3 reduced the level of C/EBPbeta, a transcription factor required for an early stage of adipogenesis, through a proteasome-dependent mechanism. Furthermore, knockdown of endogenous TRB2 by siRNA allowed 3T3-L1 cells to differentiate without full differentiation stimuli. These results suggest that inhibition of Akt activation in combination with degradation of C/EBPbeta is the basis for the strong inhibitory effect of TRB2 on adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576771     DOI: 10.1074/jbc.M701409200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells.

Authors:  Morten Ø Andersen; Jens V Nygaard; Jorge S Burns; Merete K Raarup; Jens R Nyengaard; Cody Bünger; Flemming Besenbacher; Kenneth A Howard; Moustapha Kassem; Jørgen Kjems
Journal:  Mol Ther       Date:  2010-08-31       Impact factor: 11.454

2.  Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.

Authors:  Shu-Chen Wei; Ian M Rosenberg; Zhifang Cao; Alan S Huett; Ramnik J Xavier; Daniel K Podolsky
Journal:  Inflamm Bowel Dis       Date:  2012-01-23       Impact factor: 5.325

3.  Inhibitory effects of baicalin in the early stage of 3T3-L1 preadipocytes differentiation by down-regulation of PDK1/Akt phosphorylation.

Authors:  Dong Hoon Kwak; Ji-Hye Lee; Kwang Hoon Song; Jin Yeul Ma
Journal:  Mol Cell Biochem       Date:  2013-10-04       Impact factor: 3.396

4.  Upregulation of TRB2 induced by miR-98 in the early lesions of large artery of type-2 diabetic rat.

Authors:  Shuyang Xie; Ning Xie; Youjie Li; Pingyu Wang; Chao Zhang; Qiang Li; Xiaolin Liu; Jingti Deng; Can Zhang; Changjun Lv
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

5.  Loss of c/EBP-beta activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons.

Authors:  Marc W Halterman; Christopher De Jesus; David A Rempe; Nina F Schor; Howard J Federoff
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

6.  TIPping the balance in adipogenesis: USP7-mediated stabilization of Tip60.

Authors:  Yuan Gao; Eric Kalkhoven
Journal:  Adipocyte       Date:  2014-02-25       Impact factor: 4.534

7.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

8.  Control of adipose tissue inflammation through TRB1.

Authors:  Anke Ostertag; Allan Jones; Adam J Rose; Maria Liebert; Stefan Kleinsorg; Anja Reimann; Alexandros Vegiopoulos; Mauricio Berriel Diaz; Daniela Strzoda; Masahiro Yamamoto; Takashi Satoh; Shizuo Akira; Stephan Herzig
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

9.  Tribbles-2 is a novel regulator of inflammatory activation of monocytes.

Authors:  Katalin Eder; Hongtao Guan; Hye Y Sung; Jon Ward; Adrienn Angyal; Michelle Janas; Gabriella Sarmay; Erno Duda; Martin Turner; Steven K Dower; Sheila E Francis; David C Crossman; Endre Kiss-Toth
Journal:  Int Immunol       Date:  2008-10-24       Impact factor: 4.823

10.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Authors:  N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.